🔎 Trials Near Me

Home › Heart Failure › North Carolina

Heart Failure clinical trials in North Carolina

42 studies for Heart Failure are looking for participants at sites in North Carolina.

Cities in North Carolina

ELEVATE-HFpEF Clinical Study

  • Duke University Medical Center, Durham
Recruiting
Ages 40 and older · All sexes · Updated Oct 2, 2026 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  • Research Site, Asheville
  • Research Site, Chapel Hill
  • Research Site, Charlotte
  • and 3 more
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Oct 2, 2026 · NCT06307652

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  • IMA Clinical Research Lenoir, Lenoir
  • Pinehurst Medical Clinic, Inc. - East, Pinehurst
  • Piedmont Healthcare, Inc., Statesville
  • and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06935370

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Medication Management, LLC, Greensboro
  • WakeMed, Raleigh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06424288

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

  • Wake Forest University, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Sep 29, 2026 · NCT06517186

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

  • Wake Forest University, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Sep 29, 2026 · NCT05873634

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Chapel Hill
  • Research Site, Durham
  • Research Site, Greensboro
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117

BiVACOR® Total Artificial Heart Early Feasibility Study

  • Duke University Hospital, Durham
Recruiting
Ages 18 to 70 · All sexes · Updated Sep 28, 2026 · NCT06174103

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • WakeMed Heart & Vascular - Cary Cardiology, Cary
  • Clinical and Translational Research Center - University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University Hospital, Durham
  • and 2 more
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574

A Study of LY3971297 in Participants With Heart Failure

  • University of North Carolina, Division of Cardiology, Chapel Hill
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Sep 22, 2026 · NCT07547540

Alleviant ALLAY-HFrEF Study

  • Mission Hospital, Asheville
  • Duke University Hospital, Durham
  • NC Heart and Vascular Research, Raleigh
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06812533

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Asheville Cardiology Associates, Asheville
  • Duke University Health System, Durham
  • Ima Clinical Research - Lenoir, Lenoir
  • and 2 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Charlotte
  • Research Site, Durham
  • Research Site, Fayetteville
  • and 6 more
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

  • CON-10318, Charlotte, NC, Charlotte
  • Greenville, NC Investigative Site CON-10122, Greenville
  • Morrisville, NC Investigative Site CON-10317, Morrisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Greenville, NC Investigative Site 10122, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • Duke University, Durham
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  • Sanger Heart and Vascular Institute, Charlotte
  • Duke University Medical Center, Durham
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07069738

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 159, Greensboro
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

  • Atrium Health Sanger Heart and Vascular Institute, Charlotte
Recruiting
Ages 21 and older · All sexes · Updated Aug 25, 2026 · NCT05677100

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Duke University Health System, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Durham
  • Raleigh
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

  • Focus Clinical Research, Charlotte
  • Duke University Health System, Durham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Durham
  • Tenax Investigational Site, Winston-Salem
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Peak Clinical Trials, Apex
  • Hawthorne Health NC, Concord
  • Duke University, Durham
  • and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001

Alleviant ALLAY-HF Study

  • Mission Hospital, Asheville
  • Duke University Hospital, Durham
  • NC Heart and Vascular Research, Raleigh
Recruiting
Ages 40 and older · All sexes · Updated Aug 14, 2026 · NCT05685303

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Duke University Hospital, Durham
RecruitingPhase 2
Ages 0 to 16 · All sexes · Updated Aug 10, 2026 · NCT06080074

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

  • Sanger Heart and Vascular Institute, Charlotte
Recruiting
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT06096675

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

  • FIN-10318, Charlotte, NC, Charlotte
  • Greenville, NC Investigative Site FIN-10122, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT06033950

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • UNC Medical Center, Durham
  • Duke University, Durham
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Carolinas Medical Center, Charlotte
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  • Moses H. Cone Memorial Hospital, Greensboro
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056

BOOST: Blended Onsite and Offsite Structured Exercise Training and Coaching

  • Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 55 and older · All sexes · Updated May 26, 2026 · NCT07413198

Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction

  • Duke, Durham
Recruiting
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06733012

Developing a Digital Aid to Improve ICD Decisions

  • Eastern Carolina University, Greenville
Recruiting
Ages 60 and older · All sexes · Updated Apr 27, 2026 · NCT07084142

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

  • UNC Eastowne Kidney Transplant Clinic, Chapel Hill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06059664

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  • Duke University Medical Center, Durham
Recruiting
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06895070

His-Bundle Corrective Pacing in Heart Failure

  • Mission Health, Asheville
Recruiting
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT05265520

Supporting Health in Veterans With Heart Failure

  • VA Clinic - Durham, Durham
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 13, 2025 · NCT05839067

Left vs Left Randomized Clinical Trial

  • MH Mission Hospital LLLP- Asheville Cardiology Associates, Asheville
  • University of North Carolina, Chapel Hill
  • Novant Health, Charlotte
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05650658

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.